title: NR4A2 mutations are rare among European patients with familial Parkinson's disease.
authors.forename: Claudia
authors.initials: C
authors.lastname: Wellenbrock
authors.forename: Katja
authors.initials: K
authors.lastname: Hedrich
authors.forename: Nora
authors.initials: N
authors.lastname: Schäfer
authors.forename: Meike
authors.initials: M
authors.lastname: Kasten
authors.forename: Helfried
authors.initials: H
authors.lastname: Jacobs
authors.forename: Eberhard
authors.initials: E
authors.lastname: Schwinger
authors.forename: Johann
authors.initials: J
authors.lastname: Hagenah
authors.forename: Peter P
authors.initials: PP
authors.lastname: Pramstaller
authors.forename: Peter
authors.initials: P
authors.lastname: Vieregge
authors.forename: Christine
authors.initials: C
authors.lastname: Klein
mesh_terms: D000328:Adult; D004252:DNA Mutational Analysis; D004268:DNA-Binding Proteins / Q000235:genetics*; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D020734:Parkinsonian Disorders / Q000453:epidemiology* / Q000235:genetics*; D016133:Polymerase Chain Reaction; D014157:Transcription Factors / Q000235:genetics*
chemical_list: D004268:DNA-Binding Proteins; C539882:NR4A2 protein, human; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D014157:Transcription Factors